ClinicalTrials.gg
RecruitingNCT0704108601-PainUpdated Jan 15, 2026

Prehospital ECPR in Moravia Silesia Region

An observational study in Cardiac Arrest, Out-Of-Hospital, sponsored by University Hospital Ostrava. Recruiting at 2 sites in Czechia. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-01-15.

Sponsored by University Hospital Ostrava · Observational

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia — 5 open to participants now, 5 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · Czechia.

Started
2025
with 2 others
Observational
4 of 10
2 open now
Registered
7th of 10
by date
Lead sponsor
4 of 10
University Hospital Ostrava

Among the 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia, this one is one of 3 that started in 2025, is one of 4 observational ones, and was the 7th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

5 of the 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia, or all of them as a file.
02

Study summary

Cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest (OHCA) in specific cases could be improved by Extracorporeal membrane oxygenation (ECMO; ECPR). ECPR could be introduced in hospital after retrieval of an OHCA patient and also faster by implantation on scene. The aim is to verify the effectiveness of ECPR on scene in the Moravian-Silesian region.

Read the detailed description

Patients undergoing cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest (OHCA) have a poor prognosis and a good long-term neurological outcome is achieved in about 10% of them. Extracorporeal membrane oxygenation (ECMO) can lead to an improvement in neurological outcome of up to 30% in a selected group of these critically ill patients. CPR for OHCA using ECMO in the hospital after patient admission (ECPR) is very demanding and depends on the best collaboration of pre-hospital care components with the hospital management. As good as the coordination of the different phases of care and transport is, patients often arrive to the hospital relatively late (over 60 minutes), and although the process of diagnosis and indication and ECMO implantation itself is rapid (approximately 15 minutes), the overall time from collapse to ECMO initiation is relatively long (over 60 minutes). It is this time, i.e. the duration of low organ perfusion during CPR, that may be the key parameter in determining the overall neurological outcome of treatment and prognosis of patients. Shortening this interval by having the ECMO team go to well-defined OHCA cases simultaneously with the ambulance car of the Emergency Department and connecting the patient to ECMO already in the field may lead to an improvement in the neurological outcome of the treatment of OHCA patients. In many locations abroad, this model is already used, and patients are connected to ECMO already in the field. Whether the model of field ECPR can be used in the Moravian-Silesian Region depends on a number of variables. These include the logic of information acquisition and selection of suitable patients, the logic of transporting the team and material to the scene, and the logic of connection with the provision of a safe and suitable environment for the ECMO implantation itself. The goal of this study is to validate the feasibility of the method on a simulated ECPR OHCA and further implant the mobile ECPR project in the Moravian-Silesian region.

03

Conditions studied

  • Cardiac Arrest, Out-Of-Hospital

Keywords

  • ECMO
  • Cardiac arrest
  • Cardiopulmonary resuscitation
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients after out-of-hospital cardiac arrest

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Observed collapse and presumption of cardiac cause of cardiac arrest
  • Estimated age up to 70 years
  • Baseline rhythm of ventricular fibrillation or pulseless electrical activity (PEA)
  • Basic bystander cardiopulmonary resuscitation (CPR), "bystander CPR", telephone assisted CPR (TANR)

Exclusion criteria

Exclusion Criteria:

  • Children or adults with estimated weight below 40 kg
  • Known major comorbidities of the patient suggesting low rehabilitation potential (e.g. (COPD) IV, in tertiary phase)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Out-of-hospital cardiac arrest on ECMO

    Patients with out-of-hospital cardiac arrest indicated for ECMO

    Procedure: Extracorporeal membrane oxygenation (ECMO)

Interventions

  • ProcedureExtracorporeal membrane oxygenation (ECMO)

    In extracorporeal membrane oxygenation (ECMO), blood is pumped outside of the body to a heart-lung machine. The machine removes carbon dioxide and sends oxygen-rich blood back to the body. Blood flows from the right side of the heart to the heart-lung machine. It's then rewarmed and sent back to the body.

06

What researchers measure

Primary outcomes

  1. Time from cardiac arrest (collapse) to implantation of ECMO

    The time from cardiac arrest (collapse) to implantation of ECMO will be recorded and assessed

    Time frame: up to 60 minutes

  2. Hospital mortality

    Hospital mortality will be assessed for the period of 3 weeks

    Time frame: up to 3 weeks

  3. Cerebral Performance Category (CPC) score

    Cerebral Performance Category (CPC) score will be observed 30 days after cardiac arrest

    Time frame: 30 days

  4. Neurological outcome (CPC score)

    Neurological outcome will be assessed using the Cerebral Performance Category Scale (CPC) 6 months after cardiac arrest.

    Time frame: 6 months

  5. Neurological outcome (SF-36)

    Neurological outcome will be assessed using the Short Form 36 Health Subject Questionnaire (SF-36) 6 months after cardiac arrest.

    Time frame: 6 months

  6. Neurological outcome (EQ-5D)

    Neurological outcome will be assessed using the European Quality of Life Questionnaire (EQ-5D) 6 months after cardiac arrest.

    Time frame: 6 months

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is no plan to make individual participant data available to other researchers. The data may be provided upon request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Dec 2028, 42 months after the start.

Of 69 non-industry observational studies under Out-of-Hospital Cardiac Arrest, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 75. This study's planned 42 months is close to that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 20 and three quarters within 75.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2025
First posted
Jun 27, 2025
StartActual
Jun 17, 2025
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Jan 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07041086
Collaborators
Emergency Medical Services, Moravian-Silesian Region
Responsible party
Sponsor
First posted
Jun 27, 2025
Start date
Jun 17, 2025
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jan 15, 2026

Study contacts

Jiří Hynčica
Contact
jiri.hyncica@fno.cz
0042059737 ext. 2587
Filip Burša, MD, PhD, EDEC
principal investigator · University Hospital Ostrava

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion